High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
- 23 January 2008
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 27 (6), 433-437
- https://doi.org/10.1007/s10096-007-0455-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- An Association between Reduced Susceptibility to Daptomycin and Reduced Susceptibility to Vancomycin in Staphylococcus aureusClinical Infectious Diseases, 2006
- Diminished Susceptibility to Daptomycin Accompanied by Clinical Failure in a Patient With Methicillin-Resistant Staphylococcus aureus BacteremiaInfection Control & Hospital Epidemiology, 2006
- Treatment Failure Resulting from Resistance of Staphylococcus aureus to DaptomycinJournal of Clinical Microbiology, 2006
- Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and OsteomyelitisJournal of Clinical Microbiology, 2006
- Adaptation of Methicillin-Resistant Staphylococcus aureus in the Face of Vancomycin TherapyClinical Infectious Diseases, 2006
- Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2005
- Daptomycin‐Resistant, Methicillin‐ResistantStaphylococcus aureusBacteremiaClinical Infectious Diseases, 2005
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004